Abstract
Quality of life is a complex and difficult-to-define concept with physical, spiritual, and psychosocial components. This concept is directly dependent on the health status of an individual and closely related to the subjective perception of well-being. During the past decade substantial efforts have been made to find measurable parameters of “health-related quality of life” (HRQOL) and to define a standardized health status instrument. Different quality of life studies based on patient self-assessment reports (Mackworth et al. 1992) or using multiple instruments (Taphoorn et al. 1992) have been used for this purpose.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aaronson NK, Ahmedzai S, Bergman B, et al. (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365–376
Aaronson NK, Bakker W, Stewart AL, et al. (1987) Multi-dimensional approach to the measurements of quality of life in lung cancer clinical trials. In: Aaronson NK, Beckmann JH (eds) The quality of life of cancer patients. Raven Press, New York, pp 63–82
Aaronson NK, Bullinger M, Ahmedzai S (1988) A modular approach to quality-of-life assessment in cancer clinical trials. Recent Results Cancer Res 111: 231–249
Abrey LE, DeAngelis ML, Yahalom J (1998) Long-term survival in primary CNS lymphoma. J Clin Oncol 16: 859–863
Alexander E, Moriarty TM, Davis RB, et al. (1995) Stereotactic radiosurgery for definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 87: 34–40
Barr RD, Simpson T, Whitton A, et al. (1999) Health-related quality of life in survivors of tumors of the central nervous system in childhood: a preference-based approach to measurement in a cross-sectional study. Eur J Cancer 35: 248–255
Black PM (1991) Brain tumors. Second of two parts. N Engl J Med 324: 1555–1564
Bleyer WA, Griffin TW (1980) White matter necrosis, mineralizing microangiopathy, and intellectual abilities in survivors of childhood leukemia. In: Gilbert HA, Kagan AR (eds) Radiation damage to the nervous system. Raven Press, New York, p 155
Burger PC, Kamenar E, Schold CS (1981) Encephalomyelopathy following high-dose BCNU therapy. Cancer 48: 1318–1327
Cairncross JG, Macdonald D, Ludwin S, et al. (1994) Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 12: 2013–2021
Chen JCT, Petrovich Z, ODay S, et al. (2000) Stereotactic radiosurgery in the treatment of metastatic disease to the brain. Neurosurg (In press)
Constine LS (1998) Tumors in children in cure with preservation of function and aesthetics. In: Wilson JF, (ed) Syllabus: A categorical course in radiation therapy. RSNA, Oak Brook, IL, pp 75–91
Danoff BF, Cowchock FS, Marquette C, et al. (1982) Assessment of the long-term effects of primary radiation therapy for brain tumors in children. Cancer 49: 1580–1586
Davis DG, Patchell RA (1988) Neurologic complications of bone marrow transplantation. Neurol Clin 6: 377–387
DeAngelis LM, Shapiro WR (1991) Drug/radiation interactions and central nervous system injury. In: Gutin PH, Leibel SA, Sheline GE, (eds) Radiation injury to the nervous system. Raven Press, New York, p 361
DeAngelis LM, Yahalom J, Thaler HT, et al. (1992) Combined modality treatment for primary CNS lymphoma. J Clin Oncol 10: 635–643
Duffner PK, Cohen ME, Thomas PR, et al. (1985) The long term effects of cranial irradiation on the central nervous system. Cancer (Suppl) 56: 1841–1846
Feeny D, Furlong W, Barr RD, et al. (1992) A comprehensive multiattribute system for classifying the health status of survivors of childhood cancer. J Clin Oncol 10: 923–928
Feun LG, Wallace S, Yung WK, et al. (1984) Phase I trial of intracarotid BCNU and cisplatin in patients with malignant intracerebral tumors. Cancer Drug Deliv 1: 239–245
Fine HA, Dear KB, Loeffler JS, et al. (1993) Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585–2597
Foreman NK, Faestel PM, Pearson J, et al. (1999) Health status in 52 long-term survivors of pediatric brain tumors. J Neurooncol 41: 47–53
Glaser AW, Furlong W, Walker DA, et al. (1999) Applicability of the Health Utilities Index to a population of childhood survivors of central nervous system tumours in the U.K. Eur J Cancer 35: 256–261
Griffin TW, Rasey JS, Bleyer WA (1977) The effect of photon irradiation on blood-brain barrier permeability to methotrexate in mice. Cancer 40: 1109–1111
Hindo WA, De Trana FA, Lee MS, et al. (1970) Large dose increment irradiation in treatment of cerebral metastases. Cancer 26: 138–141
Hirsch JF, Renier D, Czernichow P, et al. (1979) Medulloblastoma in childhood. Survival and functional results. Acta Neurochir 48: 1–15
Hochberg FH, Pruitt A (1980) Assumptions in the radiotherapy of glioblastoma. Neurology 30: 907–911
Joseph J, Adler JR, Cox RS, et al. (1996) Linear acceleratorbased stereotactic radiosurgery for brain metastases: the influence of number of lesions on survival. J Clin Oncol 14: 1085–1092
Karnofsky DA, Abelman WH, Craver LF (1948) The use of nitrogen mustards in palliative treatment of carcinoma. Cancer 1: 634–656
Kleinberg L, Wallner K, Malkin MG (1993) Good performance status of long-term disease-free survivors of intracranial gliomas. Int J Radiat Oncol Biol Phys 26: 129–133
Kramer ED, Packer RJ, Ginsberg J, et al. (1997) Acute neurologic dysfunction associated with high-dose chemotherapy and autologous bone marrow rescue for primary malignant brain tumors. Pediatr Neurosurg 27: 230–237
Kun LE, Mulhern RK, Crisco JJ (1983) Quality of life in children treated for brain tumors. Intellectual, emotional and academic function. J Neurosurg 58: 1–6
Landis SH, Murray T, Bolden S, et al. (1999) Cancer statistics, 1999. Ca Cancer J Clin 49: 8–31
Lannering B, Marky I, Lundberg A, et al. (1990) Long-term sequelae after pediatric brain tumors: their effect on disability and quality of life. Med Pediatr Oncol 18: 304–310
Lavine SD, Petrovich Z, Cohen-Gadol MD, et al. (1999) Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurg 44: 59–66
LeBaron S, Zeltzer PM, Zeltzer LK, et al. (1988) Assessment of quality of survival in children with medulloblastoma and cerebellar astrocytoma. Cancer 64: 1215–1222
Leibel SA, Gutin PH, Wara WM, et al. (1989) Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 17: 1129–1139
Levin VA (1985) Chemotherapy of primary brain tumors. Neurol Clin 3: 855–866
Levin VA (1986) Pharmacokinetics and CNS chemotherapy. In: Hellmann K, Carter SK (eds) Fundamentals of cancer chemotherapy. McGraw-Hill, New York, p 28
Levin VA, Wilson CB (1981) Clinical characteristics of cancer in brain and spinal cord. In: Crook ST, Prestayko A (eds) Cancer and chemotherapy: introduction to neoplasia and antineoplastic chemotherapy. Academic Press, New York, p 167
Levin VA, Edwards MS, Wright DC, et al. (1980) Modified procarbazine, CCNU, and vincristine (PCV3) combination chemotherapy in treatment of malignant brain tumors. Cancer Treat Rep 64: 237–244
Levin VA, Wara WM, Davis RL, et al. (1985) Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas. J Neurosurg 63: 218–223
Levin VA, Silver P, Hannigan J, et al. (1990) Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18: 311–324
Mackworth N, Fobair P, Prados MD (1992) Quality of life selfreports from 200 brain tumor patients: comparisons with Karnofsky performance scores. J Neurooncol 14: 243–253
Marks JE, Baglan RJ, Prassad SC, et al. (1981) Cerebral radionecrosis: incidence and risk in relation to dose, time, fraction and volume. Int J Radiat Oncol Biol Phys 7: 243–252
Mason WP, Krol GS, DeAngelis LM (1996) Low-grade oligodendroglioma responds to chemotherapy. Neurology 46: 203–207
Massie MJ, Breitbart W, Butler R (1991) Psychiatric diagnoses and neuropsychological evaluation of patients with neurooncologic illness. In: Neuro-Oncology IV: Recent Developments in the Management of Neuro-Oncologic Illnesses [syllabus of the postgraduate course]. Sloan- Kettering Cancer Center, New York
Mehta M, Noyes W, Craig B, et al. (1997) A cost-effectiveness and cost-utility analysis of radiosurgery vs resection for single-brain metastases. Int J Radiat Oncol Biol Phys 39: 445–454
Mostow EN, Byrne J, Connelly RR, et al. (1991) Quality of life in long-term survivors of CNS tumors of childhood and adolescence. J Clin Oncol 9: 592–599
Newton HB (1994) Primary brain tumors: review of etiology, diagnosis and treatment. Am Fam Physician 49: 787–797
ONeill BP, Buckner JC, Coffey RJ, et al. (1994) Brain metastatic lesions. Mayo Clin Proc 69: 1062–1068
<refereOsoba A, Aaronson NK, Muller MJ, et al. (1996) The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 5: 139–150
Osoba D, Aaronson NK, Muller M, et al. (1997) Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma. J Neurooncol 34: 263–278
Overgaard J, Bartelink H (1995) Late effects consensus conference: RTOG/EORTC. Radiother Oncol 35:1–82
Packer RJ, Meadows AT, Rorke LB, et al. (1987) Long-term sequelae of cancer treatment on the central nervous system in childhood. Med Pediatr Oncol 15: 241–253
Passik SD, Malkin MG, Breitbart WS, et al. (1994) Psychiatric and psychosocial aspects of neurooncology. J Psychosocial Oncol 12: 101–122
Patchell RA (1995) Metastatic brain tumors. Neurol Clin 13: 915–925
Patchell RA, White CL, Clark AW, et al. (1985) Neurologic complications of bone marrow transplantation. Neurology 35: 300–306
Rosenblum ML (1990) General surgical principles, alternatives and limitations. Neurosurg Clin N Am 1: 19–36
Rubin P (1995) Special issue: late effects of normal tissues (LENT) consensus conference, including RTOG/EORTC SOMA scales, San Francisco, California August 26–28, 1992 Int J Radiat Oncol Biol Phys 31: 1035–1360
Rubin P, Constine LS, Williams JP (1997) Late effects of cancer treatment: radiation and drug toxicity. In: Perez CA, Brady LW (eds) Principles and practice of radiation oncology. Lippincott-Raven, 3rd Ed, pp 155–211
Sachsenheimer W, Piotrowski W, Bimmler T (1992) Quality of life in patients with intracranial tumors on the basis of Karnofsky’s performance status. J Neurooncol 13: 177–181
Salgado D, Costa I, Pimentel T, et al. (1996) PCV for anaplastic oligodendroglioma [abstract]. J Neurooncol 30: 150
Scerrati M, Montemaggi P, Iacoangeli M, et al. (1994) Interstitial brachytherapy for low-grade cerebral gliomas: analysis of results in a series of 36 cases. Acta Neurochir 131: 97–105
Sheline GE, Wara WM, Smith V (1980) Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6: 1215–1228
Shiau CY, Sneed PK, Shu HKG, et al. (1997) Radiosurgery for brain metastases:relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 37: 375–383
Shrieve DC, Alexander E, Wen PY, et al. (1995) Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurg 36: 275–284
Shultheiss TE, Kun LE, Ang KK, et al. (1995) Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 31: 1093–1012
Sneeuw KC, Aaronson NK, Osoba D, et al. (1997) The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care 35: 490–506
Snider S, Bashir R, Bierman P (1994) Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for Hodgkin’s disease. Neurology 44: 681–684
Sprangers MA, Cull A, Bjordal K, et al. (1993) The European Organization for Research and Treatment of Cancer approach to quality of life assessment: guidelines for developing questionnaires modules. Qual Life Res 2: 287–295
Sprangers MA, Cull A, Groenvold M, et al. (1998) The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group. Qual Life Res 7: 291–300
Stewart DJ, Grahovac Z, Benoit B, et al. (1984) Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1- nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4’-O-demethyl-1-O-(4,6-O-2-thenylidenebeta- D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors. Neurosurgery 15: 828–833
Taphoorn MJ, Heimans JJ, Snoek FJ, et al. (1992) Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry 55: 372–376
Tfayli A, Hentschel P, Madajewicz S, et al. (1999) Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors. J Neurooncol 42: 73–77
Trojanowski T, Peszynski J, Turowski K, et al. (1989) Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy. J Neurosurg 70: 18–23
Vasantha Kumar AR, Renaudin J, Wilson CB, et al. (1974) Procarbazine hydrochloride in the treatment of brain tumors. J Neurosurg 40: 365–371
Weiss HD, Walker MD, Wiernik PH (1974) Neurotoxicity of commonly used antineoplastic agents. N Engl J Med 291: 127–133
Weitzner MA, Meyers CA (1997) Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psychooncology 6: 169–177
Weitzner MA, Meyers CA, Gelke CK, et al. (1995a) The Functional Assessment of Cancer Therapy (FACT) Scale Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75: 1151–1161
Weitzner MA, Meyers CA, Valentine AD (1995b) Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment. J Neuropsychiatry Clin Neurosci 7: 347–350
Werner-Wasik M, Rudoler S, Preston PE, et al. (1999) Immediate side effects of stereotactic radiotherapy and radiosurgery. Int J Radiat Oncol Biol Phys 43: 299–304
Whitton AC, Rhydderch H, Furlong W, et al. (1997) Self-reported comprehensive health status of adult brain tumor patients using the Health Utilities Index. Cancer 80: 258–265
Wiznitzer M, Packer RJ, August CS, et al. (1984) Neurological complications of bone marrow transplantation in childhood. Ann Neurol 16: 569–576
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Formenti, S.C., Petrovich, Z. (2003). Toxicity of Therapy and Quality of Life in Patients Treated for CNS Tumors. In: Petrovich, Z., Brady, L.W., Apuzzo, M.L.J., Bamberg, M. (eds) Combined Modality Therapy of Central Nervous System Tumors. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56411-6_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-56411-6_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00627-5
Online ISBN: 978-3-642-56411-6
eBook Packages: Springer Book Archive